After orchestrating a series of moves to help cancer patients, the FDA’s acting commissioner appears to be on the inside track for a perman...

A new, influential patient advocacy group brought together senior FDA leadership and a biotechnology company to accelerate ALS research ...

The ALS Association (ALSA) is distancing itself from a researchers who is mired in controversy